Literature DB >> 27797843

Endocarditis and monocular blindness.

Jack Andrews1,2, Shyamanga Borooah3.   

Abstract

A man aged 77 years with postrenal transplant lymphoproliferative disease was admitted with high fever, elevated inflammatory markers and a heart murmur. Blood cultures grew Enterococcus faecalis and he was found to have mitral valve endocarditis on echocardiogram and subsequently started on appropriate antibiotics. 5 days into treatment, he developed ocular symptoms and 3 days later, he had irreversible monocular visual loss. He was seen by the ophthalmology team who diagnosed endogenous endopthalmitis secondary to bacteraemic spread from his endocarditis. Despite treatment with intravitreal antibiotics and prolonged systemic antibiotics, his sight did not recover. Although septic emboli are common in endocarditis, endogenous endophthalmitis is rarely reported and frequently results in visual loss. Early treatment confers an improved prognosis. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27797843      PMCID: PMC5093839          DOI: 10.1136/bcr-2016-217345

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center.

Authors:  Monica I Binder; Jimmy Chua; Peter K Kaiser; Gary W Procop; Carlos M Isada
Journal:  Medicine (Baltimore)       Date:  2003-03       Impact factor: 1.889

2.  Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study.

Authors:  A A Okada; R P Johnson; W C Liles; D J D'Amico; A S Baker
Journal:  Ophthalmology       Date:  1994-05       Impact factor: 12.079

3.  Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia.

Authors:  Jiwon Jung; Junyeop Lee; Shi Nae Yu; Yong Kyun Kim; Ju Young Lee; Heungsup Sung; Mi-Na Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Joo Yong Lee; Yang Soo Kim; Yong Pil Chong
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.